Jump to content

Fulcrum stock slumps after muscle disorder drug fails in late-stage study


Recommended Posts

  • Author
​FSHD is a genetic disorder that causes muscle weakness and wasting in the face, shoulder blades and upper arms. The estimated prevalence of the disease is about 4 cases per 100,000 individuals, according to the Muscle Dystrophy Association.

Source Link


View full article

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

×
×
  • Create New...

Important Information

Cookie Consent & Terms We use cookies to enhance your experience on our site. By continuing to browse our website, you agree to our use of cookies as outlined in our We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue.. Please review our Terms of Use, Privacy Policy, and Guidelines for more information.